Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan · Delayed Price · Currency is TWD 132.00
+4.00 (3.13%)
May 15, 2026, 1:30 PM CST
Lumosa Therapeutics Market Cap
Lumosa Therapeutics has a market cap or net worth of 21.44 billion as of May 15, 2026. Its market cap has decreased by -19.66% in one year.
Market Cap
21.44B
Enterprise Value
20.70B
Revenue
31.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
132.00
Market Cap Chart
Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 21.44B, an increase of 399.15%. That is a compound annual growth rate of 16.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 21.52B | -34.32% |
| Dec 31, 2025 | 32.77B | -22.40% |
| Dec 31, 2024 | 42.22B | 274.74% |
| Dec 29, 2023 | 11.27B | 75.37% |
| Dec 30, 2022 | 6.43B | 5.04% |
| Dec 30, 2021 | 6.12B | 17.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 33.26B |
| Oneness Biotech | 24.92B |
| Sunmax Biotechnology | 20.75B |
| Medigen Vaccine Biologics | 16.11B |
| AP Biosciences | 15.19B |
| CHO Pharma | 14.94B |
| Polaris Group | 14.62B |
| TaiMed Biologics | 14.48B |